PTGX
Protagonist Therapeutics Inc

3,285
Loading...
Loading...
Protagonist Therapeutics, Inc. a clinical-stage biopharmaceutical company, which engages in discovering and developing peptide-based therapeutic drugs to address unmet medical needs. Its product pipeline includes PTG-300, PTG-200, and PN-943. The company was founded by Mark L. Smythe on August 22, 2006 and is headquartered in Newark, CA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
126

Frequently Asked Questions

What is Market Cap of Protagonist Therapeutics Inc?
What is the 52-week high for Protagonist Therapeutics Inc?
What is the 52-week low for Protagonist Therapeutics Inc?
What is Protagonist Therapeutics Inc stock price today?
What was Protagonist Therapeutics Inc stock price yesterday?
What is the PE ratio of Protagonist Therapeutics Inc?
What is the Price-to-Book ratio of Protagonist Therapeutics Inc?
What is the 50-day moving average of Protagonist Therapeutics Inc?
How many employess does Protagonist Therapeutics Inc has?

Latest PTGX News

View

Advertisement. Remove ads.

Advertisement. Remove ads.